Immunotherapy before surgery may help eradicate high-risk breast cancer

[News]

A new study led by Yale Cancer Center researchers shows women with high-risk HER2-negative breast cancer treated before surgery with immunotherapy, plus a PARP inhibitor with chemotherapy, have a higher rate of complete eradication of cancer from the breast and lymph nodes compared to chemotherapy alone.

More... (https://www.news-medical.net/news/20200428/Immunotherapy-before-surgery-may-help-eradicate-high-risk-breast-cancer.aspx)